Autor(es): Genchi, Marco; Pengo, Graziano; Genchi, Claudio

Resumo: A study was carried out to assess the efficacy of a moxidectin microsphere sustained release (SR) injectable formulation (Guardian (R) SR Iniettabile, Fort Dodge (R)) for the prevention of Dirofilaria repens infection in experimentally infected dogs. On day 0, 18 Beagle dogs, 9 male dogs and 9 female dogs, weighing 12-16 kg were ranked in ascending order of body weight (b.w.) and blocked into pairs. Within each pair, dogs were allocated to Group 1 or Group 2 at random. On the same day, dogs in Group 1 were injected with 0.05 ml/kg b.w. of saline solution and dogs in Group 2 were injected with moxidectin SR at the label dose 0.17 mg/kg b.w. (0.05 ml/kg b.w.). Six months after moxidectin SR or saline injection, on day 180, each dog in the two groups was challenged with 50 infective larvae of D. repens collected from laboratory-reared, experimentally infected Aedes aegypti. Dogs were humanely euthanized on day 380 of the study, approximately 7 months from D. repens challenge. At necropsy, no worms were found in dogs treated with moxidectin SR (Group 2) while adult worms were found in saline-treated dogs (total 90; 38 males and 52 females; arithmetic mean 10, standard error 0.96, median 9, range 7-15) (Group 1 vs Group 2 P < 0.001). In this experimental study, moxidectin SR injectable showed full efficacy (100%) lasting at least 6 months, and is able to prevent subcutaneous D. repens patent infection throughout the entire transmission season in Europe. (C) 2010 Elsevier B.V. All rights reserved.

Palavras-Chave: Dirofilaria repens; Experimental infection; Moxidectin microsphere sustained release; (SR) injectable formulation; Six-month lasting efficacy

Imprenta: Veterinary Parasitology, v. 170, n. 42401, p. 167-169, 2010

Identificador do objeto digital: 10.1016/j.vetpar.2010.01.034

Descritores: Aedes aegypti - Transmission

Data de publicação: 2010

INDICADORES

ACESSO